Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / ORD SHS
-
Number of holders
-
15
-
Total 13F shares, excl. options
-
1,579,237
-
Shares change
-
+106,264
-
Total reported value, excl. options
-
$21,194,000
-
Value change
-
+$1,408,417
-
Number of buys
-
7
-
Number of sells
-
-7
-
Price
-
$13.42
Significant Holders of NEURODERM LTD - ORD SHS as of Q1 2015
19 filings reported holding M74231107 - NEURODERM LTD - ORD SHS as of Q1 2015.
NEURODERM LTD - ORD SHS has 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,579,237 shares
.
Largest 10 shareholders include ADAGE CAPITAL PARTNERS GP LLC (750,000 shares), PERCEPTIVE ADVISORS LLC (350,000 shares), BAKER BROS. ADVISORS LP (250,000 shares), Longwood Capital Partners LLC (103,167 shares), Alyeska Investment Group, L.P. (52,041 shares), Geduld E E (35,000 shares), OPPENHEIMER & CO INC (19,700 shares), GOLDMAN SACHS GROUP INC (10,907 shares), MORGAN STANLEY (3,200 shares), and TURNER INVESTMENTS, L.P. (2,000 shares).
This table shows the top 15 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.